Dienogest inhibits BrdU uptake with G0/G1 arrest in cultured endometriotic stromal cells

article OA: closed CC0 ⤵ 84 in-corpus citations
View on OpenAlex View on PubMed View at publisher
AI-generated summary by claude@2026-06, 2026-06-07

Dienogest was found to inhibit BrdU uptake and induce G0/G1 cell cycle arrest in cultured endometriotic stromal cells.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

ObjectiveTo investigate the effect of dienogest on the proliferation of endometriotic stromal cells.DesignComparative and laboratory study.SettingUniversity of Tokyo Hospital.Patient(s)Endometriotic stromal cells were isolated and cultured from ovarian endometriomas of patients undergoing surgery.Intervention(s)Dienogest was added to the cultured endometriotic stromal cells.Main outcome measure(s)5-Bromo-2'-deoxyuridine (BrdU) incorporation into DNA of the endometriotic stromal cells was measured by ELISA. Cell cycle analysis of the cultured endometriotic stromal cells was performed by flow cytometry.Result(s)Dienogest at concentration of 10(-7) M and 10(-6) M significantly inhibited BrdU incorporation into DNA at 24 and 48 hours. Dienogest significantly increased the cells in G0/G1 phase and reduced the cells in S phase and G2/M phase in 24 and 48 hours.Conclusion(s)The present study indicates that dienogest can inhibit the proliferation of the endometriotic stromal cells with G0/G1 arrest, suggesting a possible direct effect of dienogest in the treatment of endometriosis.

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Bromodeoxyuridine Cell Proliferation Endometriosis G1 Phase Nandrolone Ovarian Diseases Resting Phase, Cell Cycle Stromal Cells Adult Bromodeoxyuridine Cell Cycle Cell Cycle Cell Proliferation Cells, Cultured Contraceptives, Oral Contraceptives, Oral DNA DNA Drug Evaluation, Preclinical Endometriosis

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (32)

Cited by (50)

Source provenance

europepmc
last seen: 2026-07-28T06:14:09.330459+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-05-13T22:15:00.519696+00:00
License: CC0 · commercial use OK